OION

"We’re excited to have Oxford Innovation Finance join our investor group at such a pivotal moment. Their experience in supporting transformative early-stage companies aligns closely with our long-term strategy as we continue to grow our platform and reach more movers across the UK. This funding enables us to accelerate development across our five core verticals, deepen integration with key industry partners and expand our national footprint. Our goal is not only to simplify the home moving process but to build the market-leading platform in proptech that becomes the default destination for anyone planning a move in the UK."

"A younger patient has about a 35% chance of implant failure during their lifetime, and the leading cause of failure is loss of fixation between the bone and the implant"

"We are focused on making it easier for patients to understand their symptoms and management of their individual condition. This not only has a positive impact on their overall health, but it also allows them to successfully make decisions about their individual treatment plans in collaboration with their clinicians. Our partnerships with global pharmaceutical companies, the NHS and other healthcare providers, is making real and valuable changes to the way patients engage with and manage their health."

"FluoretiQ perfectly represents the type of highly innovative and growth-focused companies Deepbridge Capital is committed to supporting within the sector-specific Deepbridge Life Sciences EIS fund; a great example of the importance of the Enterprise Investment Scheme. Neciah has built a great team, eager to take on the significant challenge this market demands, and we are pleased to be working with them on this next exciting stage of their journey."